Our firm represents Israeli public companies traded on the Tel-Aviv Stock Exchange, as well as shareholders in such companies, on an ongoing basis in respect of securities law matters. We have also acted as counsel to issuers and an underwriter in offerings of Israeli companies on Nasdaq and the Alternative Investment Market of the London Stock Exchange (“AIM”).
- Our firm co-counselled in the NIS 25 million Initial Public Offering (IPO) of a biotech company on the Tel-Aviv Stock Exchange, including drafting the offering prospectus, responding to the underwriters’ due diligence review, and managing and preparing the offering process. Since the offering, we advise this company with respect to ongoing compliance with the Israeli securities law and regulations, including the preparation of periodical and immediate reports to the Israeli Securities Authority and the Tel-Aviv Stock Exchange, preparation of documents relating to the convening of annual and special shareholders’ meetings and as to corporate approvals and other special requirements that apply to publicly-traded companies in Israel.
- We represented Israeli companies in connection with both initial public offerings ranging from USD 40 million to USD 115 million of securities and a secondary offering of USD 150 million of securities on Nasdaq and in the preparation of their U.S. regulatory filings. We have also represented both an Israeli company and an English underwriter in connection with public offerings on the AIM. A partner in our firm has extensive experience in U.S. securities law, garnered from a renowned U.S. law firm in which he practiced securities law for many years.
- We counsel our clients, both publicly traded and privately held companies, on a wide variety of transactions involving Israeli and U.S. securities law. For example, when representing companies and investors in private capital fundraisings or in M&A transactions, we confirm securities law compliance and secure appropriate representations of the parties, we draft registration rights agreements, and anticipate and advise as to other exit-related securities issues.